Experience

Reexamination and arbitration victory for CSL Behring

CSL Behring

Finnegan represented CSL Behring in an ex parte reexamination and corresponding arbitration proceeding against Baxter and Bayer relating to Factor VIII blood products, securing a favorable settlement for our client.

Related Practices

Ex Parte Reexamination (EPR)

Global IP Enforcement, Litigation, and Trials

Arbitration and Other ADR

Related Industries

Life Sciences

Biotechnology

Biologics

Related Experiences

CSL Behring GmbH v. Shire ViroPharma Inc.

CSL Behring GmbH

Shire ViroPharma Inc. v. CSL Behring LLC

CSL Behring LLC

Arbitration victory for major U.S. pharmaceutical company

Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote®

Cumberland Pharmaceuticals

Finnegan successfully represents U.S. pharmaceutical company in an arbitration

Cumberland Pharmaceuticals v. Mylan

Cumberland Pharmaceuticals Inc.

An international arbitration tribunal rules for Finnegan client on inventorship and contract interpretation disputes

Reexamination strategy leads to settlement

Experience_Finnegan_confirms_significant_international_arbitration_awards_and_injunctive_relief_for_client_Milestone

Finnegan confirms significant international arbitration awards and injunctive relief for client Milestone Systems A/S

Milestone Systems A/S

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.